Women’s health has long been underfunded and treated as a niche market, but a new generation of companies is showing it’s one of the biggest opportunities in healthcare. This panel brings together leaders who are rethinking how women get diagnosed, access care and pay for it, with business models that range from selling directly to consumers to partnering with health plans. Panelists will discuss what’s driving this shift: who pays, how to earn trust from patients, payers and clinicians, and what it takes to scale.

Federal policy now reshapes how the U.S. prices prescription drugs. Most favored nation (MFN) pricing, which aims to align U.S. prices with those paid in other wealthy countries, has moved from proposal to negotiated agreements. This panel examines how manufacturers, payers, and providers respond, and what MFN means for patients and innovation. Panelists from manufacturing, government affairs, payer, and policy backgrounds also cover PBM reform, the Inflation Reduction Act, and 340B changes, and tackle the central question: when drug prices fall, who pays?

Bringing AI-enabled devices and robotics into healthcare requires clinical value, workflow fit, and a viable business model. This panel brings together founders, clinicians, and industry experts to examine how these technologies move from development into everyday care, from surgical and image-guided interventions to hospital automation. The discussion will explore what drives clinician adoption, how hospitals evaluate the return on investment, and what it takes to build and scale products that improve patient care.

Reaching the Last Patient brings together leaders working to reach the patients the US health system most often misses, namely those left behind by cost, fragmentation, distance, and unmet social needs. The panel explores how digital health and health technology innovation close that gap across four dimensions, namely physical and clinical reach, affordability and access infrastructure, data and informatics, and the human layer of trust and community. Through one shared conversation, these voices ask what it genuinely takes to reach the patient everyone else misses, and what they can learn from one another.
